Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
HealthBeacon PLC - Dublin-based devices and software developer for managing critical and chronic medications - In 2022, pretax loss widens to €13.2 million from €8.2 million in 2021. Revenue almost flat at €2.3 million compared to €2.2 million. Cost of sales increase 11% to €2.1 million from €1.9 million. In its outlook, firm says: ‘HealthBeacon has continued its upward trajectory in 2022 with the successful acquisition of US clients and investments.’
Current stock price: €1.30
12-month change: down 71%
Copyright 2023 Alliance News Ltd. All Rights Reserved.